Evidence map›Paper›PMID 37678740›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2024

Using Relative Survival to Estimate the Burden of Kidney Failure.

Margaret R Stedman, Manjula Kurella Tamura, Glenn M Chertow

Abstract read
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Kidney disease: a global health priority.Nature reviews. Nephrology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Margaret R StedmanDivision of Nephrology, Department of Medicine, School of Medicine, Stanford University, Stanford. Electronic address: mstedman@stanford.edu.
Manjula Kurella TamuraDivision of Nephrology, Department of Medicine, School of Medicine, Stanford University, Stanford; Geriatric Research and Education Clinical Center, Palo Alto VA Health Care System, Palo Alto, California.
Glenn M ChertowDivision of Nephrology, Department of Medicine, School of Medicine, Stanford University, Stanford; Department of Epidemiology and Population Health, School of Medicine, Stanford University, Stanford.

Funding

Mentoring Patient-Oriented Clinical Investigators in NephrologyK24DK085446 · NIDDK · STANFORD UNIVERSITY · PI CHERTOW, GLENN MATTHEW · 2010 to 2022
$1.4M
A Mentoring Program in Kidney Care for Older AdultsK24AG073615 · NIA · STANFORD UNIVERSITY · PI MANJULA KURELLA TAMURA · 2022 to 2026
$651k
Developing Tools for Dialysis Decision Support in Older AdultsI01HX002763 · VA · VETERANS ADMIN PALO ALTO HEALTH CARE SYS · PI MANJULA KURELLA TAMURA · 2020 to 2026
–
HSRD VA I01 HX002763NIA NIH HHS K24 AG073615NIDDK NIH HHS K24 DK085446
6 · The paper itself

Abstract

RATIONALE &

objectiveEstimates of mortality from kidney failure are misleading because the mortality from kidney failure is inseparable from the mortality attributed to comorbid conditions. We sought to develop an alternative method to reduce the bias in estimating mortality due to kidney failure using life table methods. STUDY

designLongitudinal cohort study. SETTING &

participantsUsing data from the US Renal Data System and the Medicare 5% sample, we identified an incident cohort of patients, age 66+, who first had kidney failure in 2009 and a similar general population cohort without kidney failure. EXPOSURE: Kidney failure. OUTCOME: Death. ANALYTICAL APPROACH: We created comorbidity, age, sex, race, and year-specific life tables to estimate relative survival of patients with incident kidney failure and to attain an estimate of excess kidney failure-related deaths. Estimates were compared with those based on standard life tables (not adjusted for comorbidity).

resultsThe analysis included 31,944 adults with kidney failure with a mean age of 77±7 years. The 5-year relative survival was 31% using standard life tables (adjusted for age, sex, race, and year) versus 36% using life tables also adjusted for comorbidities. Compared with other chronic diseases, patients with kidney failure have among the lowest relative survival. Patients with incident kidney failure ages 66-70 and 76-80 have a survival comparable to adults without kidney failure roughly 86-90 and 91-95 years old, respectively. LIMITATIONS: Relative survival estimates can be improved by narrowing the specificity of the covariates collected (eg, disease severity and ethnicity).

conclusionsEstimates of survival relative to a matched general population partition the mortality due to kidney failure from other causes of death. Results highlight the immense burden of kidney failure on mortality and the importance of disease prevention efforts among older adults. PLAIN-LANGUAGE SUMMARY: Estimates of death due to kidney failure can be misleading because death information from kidney failure is intertwined with death due to aging and other chronic diseases. Life tables are an old method, commonly used by actuaries and demographers to describe the life expectancy of a population. We developed life tables specific to a patient's age, sex, year, race, and comorbidity. Survival is derived from the life tables as the percentage of patients who are still alive in a specified period. By comparing survival of patients with kidney failure to the survival of people from the general population, we estimate that patients with kidney failure have one-third the chance of survival in 5 years compared with people with similar demographics and comorbidity but without kidney failure. The importance of this measure is that it provides a quantifiable estimate of the immense mortality burden of kidney failure.

Indexed as

MedicareRenal InsufficiencyAgedAged, 80 and overChronic DiseaseHumansLife ExpectancyLongitudinal StudiesUnited StatesComorbidity life tableskidney failurekidney failure excess mortalitykidney failure specific-survivalrelative survival

Identifiers

PMID37678740
PMCPMC10841440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.